Persistence and compliance with newly initiated antihypertensive drug treatment in patients with chronic kidney disease

BACKGROUND: Patients with chronic kidney disease initiating an antihypertensive drug (AH) treatment must persist and comply with it to slow disease progression and benefit from the reduction of cardiovascular morbidity and mortality. OBJECTIVES: This study evaluates the persistence and compliance wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Viet Thanh, Moisan, Jocelyne, Kröger, Edeltraut, Langlois, Serge, Grégoire, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922779/
https://www.ncbi.nlm.nih.gov/pubmed/27382260
http://dx.doi.org/10.2147/PPA.S108757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922779/
https://www.ncbi.nlm.nih.gov/pubmed/27382260
http://dx.doi.org/10.2147/PPA.S108757

Ejemplares similares